$4.9 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 75 reported holdings in Q1 2013. The portfolio turnover from Q4 2012 to Q1 2013 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2013 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2013-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
GRIFOLS S A | 33 | Q4 2021 | 0.9% |
ALPHABET INC | 32 | Q3 2023 | 4.2% |
SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
VISA INC | 30 | Q3 2023 | 2.9% |
WABTEC CORP | 27 | Q3 2023 | 3.6% |
EXELIXIS INC | 27 | Q3 2023 | 2.8% |
ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
Solid Power, Inc. | February 11, 2022 | ? | ? |
Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-05-24 |
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.
Compare quarters
The following issues were detected while analyzing the report:
- The reported total value is incorrect (4898485000.0 != 0.0)
- The reported number of holdings is incorrect (75 != 0)
- The reported has been restated
- The reported has been amended
Export FARALLON CAPITAL MANAGEMENT LLC's holdings